Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Alcian Blue & Nuclear Fast Red Staining Kit Guide
2026-08-24
Build high-contrast research slides for acid mucins, cartilage matrix, and mesenchymal stem cell differentiation assays with a two-dye workflow. This guide separates endpoint matrix staining from small-biopsy handling and provides practical starting conditions, controls, and troubleshooting steps.
-
RWJ 67657: A Translational p38 Inflammation Framework
2026-08-24
RWJ 67657, also known as JNJ-3026582 in research contexts, offers a selective way to interrogate p38α/β-driven TNF-alpha biology. This article connects its preclinical profile with new structural insights into kinase dephosphorylation while defining practical boundaries for translational interpretation.
-
SGI-1027: From DNMT Inhibition to Translation
2026-08-23
A translational perspective on SGI-1027 as a non-nucleoside DNA methyltransferase inhibitor, integrating its Ado-Met-competitive mechanism, DNMT1 degradation, tumor suppressor gene reactivation, and apoptosis findings in Huh7 hepatocellular carcinoma cells.
-
Bromodomain Inhibitor, (+)-JQ1: Translational Strategy
2026-08-22
Bromodomain Inhibitor, (+)-JQ1 is more than a benchmark BET bromodomain inhibitor. By connecting BRD4 engagement with apoptosis, TXNIP-regulated ferroptosis sensitivity, inflammation and cytokine storm modulation, and male contraception via BRDT inhibition, this article outlines how translational researchers can use (+)-JQ1 to build mechanism-led experiments and biomarker strategies.
-
Tacalcitol monohydrate Research Workflows
2026-08-22
Tacalcitol monohydrate enables VDR-centered experiments in keratinocyte biology, NGF induction, and colorectal cancer combination studies. This practical guide connects concentration selection, 5-fluorouracil assay design, mechanistic readouts, formulation controls, and troubleshooting for more reproducible results.
-
Rifampin Workflows for Transcription Research
2026-08-21
Rifampin provides a practical bacterial transcription-stop tool for resistance studies, RNA kinetics, and synthetic biology validation. This guide pairs disciplined DMSO handling with assay controls and explains how its bacterial mechanism differs from the light-inducible translational switch described in recent gene-therapy research.
-
Phillygenin in Diabetic Nephropathy: Pathway Evidence
2026-08-20
The reference study identifies phillygenin as a candidate intervention for diabetic nephropathy by linking reduced TLR4/MyD88/NF-κB inflammation with improved PI3K/AKT/GSK3β survival signaling. Evidence from high-glucose podocytes and db/db mice suggests that coordinated control of inflammatory injury and apoptosis can improve renal outcomes, while also highlighting the need for causal and clinical validation.
-
Torin2 Assay Design: From Viability to Cell Death
2026-08-20
Torin2 is a potent mTOR inhibitor, but interpreting its anticancer activity requires more than a single viability endpoint. This assay-focused guide connects mTOR pathway inhibition with growth arrest, apoptosis assay design, and experimentally defensible decisions in cancer research.
-
Neuroligin 1 Proteolysis in Social Memory
2026-08-19
The reference study identifies activity-dependent cleavage of Neuroligin 1 (NLG1) in the ventral hippocampus as a mechanism that helps maintain, rather than merely form, social memory. Its experiments connect α/γ-secretase processing, the NLG1 intracellular fragment, PDZ-dependent cofilin signaling, dendritic spine remodeling, and behavioral rescue.
-
Berberrubine and Vitamin K Cycling in Thrombosis
2026-08-19
This study integrates mouse thrombosis modeling, untargeted UPLC-Q-TOF/MS metabolomics, coagulation testing, and molecular docking to investigate berberrubine hydrochloride as an antithrombotic agent. Its findings associate berberrubine with altered vitamin K catalytic-cycle biology and prolonged prothrombin time without increased bleeding time, while also highlighting the need for direct biochemical and translational validation.
-
Resazurin Cell Viability Assay Kit: Practical Workflow
2026-08-18
Build a sensitive, non-toxic cell viability assay around resazurin reduction, with fluorescence for low-input screening and colorimetry for flexible routine measurements. This workflow translates ROS-apoptosis findings in lymphoid malignancies into practical plate design, controls, optimization, and troubleshooting decisions.
-
Trilaurin: From Lipid Excipient to Translational Asset
2026-08-18
Trilaurin, also known as Glycerol Tridodecanoate, is more than a water-insoluble lipid. Its defined C12 triacylglycerol structure supports two strategically important workflows: protecting oral peptide and protein payloads within solid lipid systems, and serving as a renewable biocatalytic synthesis substrate for fatty amines. This article connects mechanism, evidence, formulation strategy, and translational decision-making.
-
ATS-9R/siCcl2 Targeting of Macrophages in GDM
2026-08-17
The reference study developed an ATS-9R/siCcl2 complex to target adipose tissue macrophages and reduce CCL2-driven inflammation in gestational diabetes mellitus. Its combination of tissue-selective nucleic acid delivery, mechanistic analysis of calcium and reactive oxygen signaling, and metabolic evaluation provides a useful framework for studying insulin resistance amelioration.
-
Obeticholic Acid: Reframing FXR in Fibrosis
2026-08-17
Obeticholic Acid and 6alpha-ethyl-chenodeoxycholic acid provide a mechanistic platform for connecting bile acid homeostasis, cholestasis, inflammation, portal pressure, and liver fibrosis research. This translational perspective integrates FXR biology with recent evidence on 11β-HSD1, Notch, and NK-cell activity to guide more informative preclinical workflows.
-
SARS-CoV-2 N Protein Disrupts the GADD34–IRF3 Axis
2026-08-16
A 2024 Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA and weakens IRF3-dependent interferon signaling. The work connects viral condensate biology with innate immune evasion and provides a framework for testing how RNA localization affects antiviral gene regulation.